PGAP3

Chr 17

post-GPI attachment to proteins phospholipase 3

Also known as: AGLA546, CAB2, PERLD1, PP1498, hCOS16

This gene encodes a glycosylphosphatidylinositol (GPI)-specific phospholipase that primarily localizes to the Golgi apparatus. This ubiquitously expressed gene is predicted to encode a seven-transmembrane protein that removes unsaturated fatty acids from the sn-2 position of GPI. The remodeling of the constituent fatty acids on GPI is thought to be important for the proper association between GPI-anchored proteins and lipid rafts. The tethering of proteins to plasma membranes via posttranslational GPI-anchoring is thought to play a role in protein sorting and trafficking. Mutations in this gene cause an autosomal recessive form of neurologic hyperphosphatasia with cognitive disability (HPMRS4). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.83
Clinical SummaryPGAP3
🧬
Gene-Disease Validity (ClinGen)
hyperphosphatasia with intellectual disability syndrome 4 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
42 unique Pathogenic / Likely Pathogenic· 82 VUS of 250 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.83LOEUF
pLI 0.002
Z-score 2.05
OE 0.44 (0.250.83)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.69Z-score
OE missense 0.86 (0.750.98)
154 obs / 179.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.44 (0.250.83)
00.351.4
Missense OE?0.86 (0.750.98)
00.61.4
Synonymous OE?0.90
01.21.6
LoF obs/exp: 7 / 15.8Missense obs/exp: 154 / 179.9Syn Z: 0.67
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePGAP3-related hyperphosphatasia with intellectual developmental disorder syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7326th %ile
GOF
0.7126th %ile
LOF
0.2288th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

250 submitted variants in ClinVar

Classification Summary

Pathogenic26
Likely Pathogenic16
VUS82
Likely Benign89
Benign17
Conflicting9
26
Pathogenic
16
Likely Pathogenic
82
VUS
89
Likely Benign
17
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
18
6
2
0
26
Likely Pathogenic
10
5
1
0
16
VUS
0
80
1
1
82
Likely Benign
0
8
26
55
89
Benign
0
1
14
2
17
Conflicting
9
Total281004458239

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

8 pathogenic / likely-pathogenic (of 14) ClinVar copy-number / structural variants overlap PGAP3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PGAP3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →